Compare Mutual Funds
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹200
-
Expense Ratio
2.44
-
NAV
₹33.88
-
Fund Started
08 Feb 2019
-
Fund Size
₹84.53 Cr
-
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
-
1 Year
8.09%
-
3 Year
21.98%
-
5 Year
10.54%
-
Equity
96.12%
-
Cash
3.88%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.22% |
Apollo Hospitals Enterprise Ltd. | 6.52% |
Torrent Pharmaceuticals Ltd. | 6.50% |
Aurobindo Pharma Ltd. | 5.15% |
Divi's Laboratories Ltd. | 4.74% |
Fortis Healthcare Ltd. | 4.70% |
Neuland Laboratories Ltd. | 4.59% |
Onesource Specialty Pharma Ltd. | 4.56% |
Piramal Pharma Ltd. | 4.33% |
Glenmark Pharmaceuticals Ltd. | 3.41% |
-
Name
-
-
Start Date
-
-
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
-
Launch Date
08 Feb 2019
-
